Deinove

Latest news

18.02.2019

DEINOVE announces its financial calendar for 2019

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...

31.01.2019

Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner

The test design has been improved for a better assessment of DNV3837 effectiveness in treating...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

more info

In the Medias

01.02.2019

La Tribune | La biotech Deinove entre en phase clinique sur un antibiotique novateur

Lire l'article

10.10.2018

La Biotech.eu | How to Make Industrial Biotech Pay

Making enough money to survive long enough to get a product to market can be tough for any biotech, but even more so for companies...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias